297 related articles for article (PubMed ID: 8386213)
1. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells.
Calogero AE; Bagdy G; Moncada ML; D'Agata R
J Endocrinol; 1993 Mar; 136(3):381-7. PubMed ID: 8386213
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
[TBL] [Abstract][Full Text] [Related]
3. Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action.
Bagdy G; Calogero AE; Szemeredi K; Gomez MT; Murphy DL; Chrousos GP; Gold PW
Brain Res; 1990 Dec; 537(1-2):227-32. PubMed ID: 2150776
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
5. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y
Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
Bagdy G; Kalogeras KT
Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
[TBL] [Abstract][Full Text] [Related]
7. Role for serotonin3 receptors in the control of adrenocorticotropic hormone release from rat pituitary cell cultures.
Calogero AE; Bagdy G; Burrello N; Polosa P; D'Agata R
Eur J Endocrinol; 1995 Aug; 133(2):251-4. PubMed ID: 7655652
[TBL] [Abstract][Full Text] [Related]
8. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
Maura G; Barzizza A; Folghera S; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929
[TBL] [Abstract][Full Text] [Related]
9. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
11. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
Johansson-Wallsten CE; Berg M; Meyerson BJ
Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic-pituitary-adrenal responses to 5-HT1A and 5-HT2A/C agonists are differentially altered in female and male rats prenatally exposed to ethanol.
Hofmann CE; Ellis L; Yu WK; Weinberg J
Alcohol Clin Exp Res; 2007 Feb; 31(2):345-55. PubMed ID: 17250628
[TBL] [Abstract][Full Text] [Related]
13. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.
Anderson IK; Martin GR; Ramage AG
Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825
[TBL] [Abstract][Full Text] [Related]
14. Serotonin directly stimulates cortisol secretion from the interrenals in goldfish.
Lim JE; Porteus CS; Bernier NJ
Gen Comp Endocrinol; 2013 Oct; 192():246-55. PubMed ID: 24013027
[TBL] [Abstract][Full Text] [Related]
15. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
Vicentic A; Li Q; Battaglia G; Van de Kar LD
Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.
Zhang Y; Gray TS; D'Souza DN; Carrasco GA; Damjanoska KJ; Dudas B; Garcia F; Zainelli GM; Sullivan Hanley NR; Battaglia G; Muma NA; Van de Kar LD
J Pharmacol Exp Ther; 2004 Jul; 310(1):59-66. PubMed ID: 15064330
[TBL] [Abstract][Full Text] [Related]
17. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
Berendsen HH; Broekkamp CL
Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635.
Critchley DJ; Childs KJ; Middlefell VC; Dourish CT
Eur J Pharmacol; 1994 Oct; 264(1):95-7. PubMed ID: 7828650
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
Riekkinen P
Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
Freo U; Merico A; Ermani M; Ori C
Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
